Two months after laying off 20% of its staff, Korro Bio says it has not retreated from its “3-2-1” corporate strategy as it prepares to release interim clinical data on its lead candidate KRRO-110 in ...

Tiny fat bubbles carrying gene therapy have successfully repaired DNA in the lungs and liver of animals with alpha-1 antitrypsin deficiency — a promising leap toward treating humans with this ...

Alpha-1 antitrypsin deficiency (AATD), bronchoscopic lung volume reduction (BLVR), COPD, emphysema, endobronchial valves, hyperinflation, interventional pulmonology, lung volume reduction therapy.